News

Search EMA's news announcements

Resultaten (3786)

Investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events continues

16 maart 2021

News Human COVID-19 Vaccines

EMA’s safety committee continues investigation of COVID-19 Vaccine AstraZeneca and thromboembolic events – further update

15 maart 2021

News Human COVID-19 Vaccines

EMA Management Board – highlights of March 2021 meeting

12 maart 2021

News Corporate

Benefits of ifosfamide solutions continue to outweigh risks EMA’s safety committee (PRAC) has concluded that the benefits of ifosfamide solutions for infusion

12 maart 2021

News Human Pharmacovigilance Referrals

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 March 2021

12 maart 2021

News Human COVID-19 Pharmacovigilance Referrals

COVID-19 Vaccine AstraZeneca: PRAC investigating cases of thromboembolic events - vaccine’s benefits currently still outweigh risks - Update

11 maart 2021

News Human COVID-19 Vaccines

EMA recommends COVID-19 Vaccine Janssen for authorisation in the EU

11 maart 2021

News Human COVID-19 Vaccines

EMA website briefly unavailable on 15 March 2021

11 maart 2021

News Corporate

EMA starts rolling review of Eli Lilly antibodies bamlanivimab and etesevimab for COVID-19

11 maart 2021

News Human COVID-19 Medicines

COVID-19 Vaccine AstraZeneca: PRAC preliminary view suggests no specific issue with batch used in Austria

10 maart 2021

News Human COVID-19 Vaccines